World Journal of Gastroenterology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Sim W, Lim WM, Hii LW, Leong CO, Mai CW. Targeting pancreatic cancer immune evasion by inhibiting histone deacetylases. World J Gastroenterol 2022; 28(18): 1934-1945 [PMID: 35664961 DOI: 10.3748/wjg.v28.i18.1934]
URL:	https://www.wjgnet.com/1007-9327/full/v28/i18/1934.htm

(0) (0) (0) (9) (8385) (24)

Number	Citing Articles
1	Songyu Guo, Zhenxia Wang. Unveiling the immunosuppressive landscape of pancreatic ductal adenocarcinoma: implications for innovative immunotherapy strategies. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1349308
2	Chin-King Looi, Lian-Chee Foong, Felicia Fei-Lei Chung, Alan Soo-Beng Khoo, Ee-Mun Loo, Chee-Onn Leong, Chun-Wai Mai. Targeting the crosstalk of epigenetic modifications and immune evasion in nasopharyngeal cancer. Cell Biology and Toxicology 2023; 39(6): 2501 doi: 10.1007/s10565-023-09830-9
3	Virginia López Martínez, Mario Fernández Fraga. Cancer Immunosurveillance. Methods in Molecular Biology 2025; 2930: 203 doi: 10.1007/978-1-0716-4558-1_14
4	Jiaqi Tian, Miaomiao Han, Fuyang Song, Yun Liu, Yuhou Shen, Jiateng Zhong. Advances of HDAC inhibitors in tumor therapy: potential applications through immune modulation. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1576781
5	Jing Liu, Hua-Tao Wu, Yu Deng, Bing-Xuan Wu, Yan-Yu Hou, Ze-Xuan Fang, Zheng Wu. Review of ferroptosis in colorectal cancer: Friends or foes?. World Journal of Gastroenterology 2023; 29(3): 469-486 doi: 10.3748/wjg.v29.i3.469 Abstract(1213) \| Core Tip(1100) \| Full Article(HTML)(6755) \| Full Article (PDF)-2412K(532) \| Full Article (Word)-456K(81) \| Audio-890K(78) \| Peer-Review Report-236K(177) \| Answering Reviewers-109K(176) \| Times Cited (14) \| Total Visits (16194) \| Open
6	Yuen-Fen Tan, Ling-Wei Hii, Wei-Meng Lim, Soon-Keng Cheong, Chee-Onn Leong, Maxine Swee-Li Yee, Chun-Wai Mai. Polyethylene glycol-phospholipid functionalized single-walled carbon nanotubes for enhanced siRNA systemic delivery. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-80646-1
7	Yuxia Wu, Xiangyan Jiang, Zeyuan Yu, Zongrui Xing, Yong Ma, Huiguo Qing. Mechanisms of Anti-PD Therapy Resistance in Digestive System Neoplasms. Recent Patents on Anti-Cancer Drug Discovery 2025; 20(1): 1 doi: 10.2174/0115748928269276231120103256
8	Deju Anna Kong, Huang Wang, Mingzhen Wang, Siyu Chen, Dingge Cao, Xujun Liu, Liyan Cui, Wenzhe Si. The histone acylation network: emerging therapeutic targets for remodeling the epigenetic landscape in pancreatic ductal adenocarcinoma. Cellular Oncology 2026; 49(2) doi: 10.1007/s13402-026-01191-9
9	Runling Lin, Yu Zhang, Hong Li, Fan Liang. Histone deacetylases: Function in tumor development and therapeutic prospects (Review). Oncology Letters 2026; 31(4): 1 doi: 10.3892/ol.2026.15497
10	Jia-Dan Zhou, Hong-Zhang Shen. Advances in pancreatic cancer epigenetics: From the mechanism to the clinic. World Journal of Gastrointestinal Oncology 2025; 17(7): 106238 doi: 10.4251/wjgo.v17.i7.106238 Abstract(222) \| Core Tip(246) \| Full Article(HTML)(900) \| Full Article with Cover (PDF)-824K(93) \| Audio-361K(9) \| Peer-Review Report-246K(55) \| Answering Reviewers-117K(49) \| Full Article (PDF)-517K(128) \| Full Article (XML)-283K(62) \| Times Cited (4) \| Total Visits (3491) \| Open
11	Zihao Liu, Zhiguang Yang. Histone deacetylase-based dual inhibitors: research progress focusing on non-small cell lung cancer therapy. RSC Medicinal Chemistry 2026; doi: 10.1039/D6MD00063K
12	Jian Hong, Saber Y. Adam, Shiqi Wang, Hao Huang, In Ho Kim, Abdelkareem A. Ahmed, Hao-Yu Liu, Demin Cai. Melatonin Modulates ZAP70 and CD40 Transcripts via Histone Modifications in Canine Ileum Epithelial Cells. Veterinary Sciences 2025; 12(2): 87 doi: 10.3390/vetsci12020087
13	Xinyao Huang, Renjun Gu, Ziyun Li, Fangyu Wang. Igniting Cold Tumors: Multi-Omics-Driven Strategies to Overcome Immune Evasion and Restore Immune Surveillance. Oncology Research 2025; 33(10): 2857 doi: 10.32604/or.2025.066805
14	María Carretero-Fernández, Lucía Ruíz-Durán, Pinar Uysal-Onganer, Neil Daniel, Eugenia Yiannakopoulou, Burçak Otlu, Francisco José García-Verdejo, José Antonio López-López, Francisco Gabriel Ortega Sánchez, Marco Bonilla, Francisco Mesa, Fernando Reyes-Zurita, Juan Francisco Gutiérrez-Bautista, Carmen González-Olmedo, Martín A. Fernández-Baldo, Daniele Campa, Pedro Sánchez-Rovira, David Hughes, Antonio José Cabrera-Serrano, Juan Sainz. Non-coding RNAs as biomarkers and therapeutic targets in pancreatic cancer: Clinical implications and translational perspectives. Biomedicine & Pharmacotherapy 2026; 199: 119394 doi: 10.1016/j.biopha.2026.119394
15	Sophia Ogechi Ekeuku, Effiong Paul Etim, Kok-Lun Pang, Kok-Yong Chin, Chun-Wai Mai. Vitamin E in the management of pancreatic cancer: A scoping review. World Journal of Gastrointestinal Oncology 2023; 15(6): 943-958 doi: 10.4251/wjgo.v15.i6.943 Abstract(1004) \| Core Tip(963) \| Full Article(HTML)(3407) \| Full Article with Cover (PDF)-1316K(258) \| Full Article (Word)-652K(82) \| Audio-232K(22) \| Peer-Review Report-285K(176) \| Answering Reviewers-200K(159) \| Full Article (PDF)-1012K(300) \| Full Article (XML)-221K(199) \| Times Cited (9) \| Total Visits (9831) \| Open
16	Lei Jin, Daohai Qian, Xiaolei Tang, Yong Huang, Junwei Zou, Zhaoying Wu. SMYD2 Imparts Gemcitabine Resistance to Pancreatic Adenocarcinoma Cells by Upregulating EVI2A. Molecular Biotechnology 2024; 66(10): 2920 doi: 10.1007/s12033-023-00908-7
17	Chin-King Looi, Li-Lian Gan, Wynne Sim, Ling-Wei Hii, Felicia Fei-Lei Chung, Chee-Onn Leong, Wei-Meng Lim, Chun-Wai Mai. Histone Deacetylase Inhibitors Restore Cancer Cell Sensitivity towards T Lymphocytes Mediated Cytotoxicity in Pancreatic Cancer. Cancers 2022; 14(15): 3709 doi: 10.3390/cancers14153709
18	Yijia Tang, Guangzu Cui, Haicong Liu, Ying Han, Changjing Cai, Ziyang Feng, Hong Shen, Shan Zeng. Converting “cold” to “hot”: epigenetics strategies to improve immune therapy effect by regulating tumor‐associated immune suppressive cells. Cancer Communications 2024; 44(6): 601 doi: 10.1002/cac2.12546
19	Muhammad Tufail, Can-Hua Jiang, Ning Li. Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. Signal Transduction and Targeted Therapy 2025; 10(1) doi: 10.1038/s41392-025-02280-1
20	Mihaela Andreescu. Epigenetic Alterations That Are the Backbone of Immune Evasion in T-cell Malignancies. Cureus 2024; doi: 10.7759/cureus.51662
21	Jie Xu, Yaomei Tian, Die Hu, Xi Yan, Li Yang. Enhancing cancer immunotherapy and antiangiogenic therapy by regulating gut microbes: Opportunities and challenges. MedComm – Oncology 2024; 3(3) doi: 10.1002/mog2.85
22	Zeynep Akpınar, Nilgün Gürbüz. Carvacrol is a Novel Natural Therapeutic Approach Through the Inhibition of Proliferation, Autophagy and Migration in Pancreatic Ductal Adenocarcinoma Cells. SDÜ Tıp Fakültesi Dergisi 2024; doi: 10.17343/sdutfd.1560561
23	Renzo Vera, María Julia Lamberti, Alina L. Gonzalez, Martín E. Fernandez-Zapico. Epigenetic regulation of the tumor microenvironment: A leading force driving pancreatic cancer. Pancreatology 2024; 24(6): 878 doi: 10.1016/j.pan.2024.07.005
24	Peizan Ni, Lilin Li, KunPeng Du, Pengkhun Nov, Duanyu Wang, Changqian Wang, Qianzi Kou, Ying Li, Yangfeng Zhang, Chongyang Zheng, Wen Fu, Jiqiang Li. Unveiling the immunological terrain of pancreatic ductal adenocarcinoma: strategies to prompt immunotherapy from Mendelian randomization. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02250-7